WASHINGTON, June 9 /PRNewswire/ -- The Biotechnology Industry
Organization (BIO) announced today that 76 biotech companies have been
selected to present their business plans for pharmaceutical company
representatives and investors at BIO VentureForum East 2006, scheduled from
June 12-14 at the Hyatt Regency on the Hudson in Jersey City, NJ.
BIO VentureForum East is the largest annual East Coast regional
investor conference for venture stage biotechnology and healthcare firms.
It features plenary sessions and workshops on financing and partnering
trends in the biotechnology industry, networking receptions, and
presentations by biotech companies which have been selected by an advisory
board of leading equity capital leaders.
The 76 presenting companies are involved in research of a wide array of
technologies, from medical devices, diagnostics and drug delivery to
vaccines and gene therapy to oncology, neurology and infectious diseases.
This conference is a valuable opportunity for pharmaceutical companies
interested in licensing and partnering to learn about emerging
biotechnology companies with innovative research and novel therapeutic
expertise. Representatives of Biogen Idec, Inc., Bristol-Myers Squibb
Company, Johnson & Johnson Development Corp., Merck & Co., Inc., and
Pfizer, Inc. have registered to attend.
Mervyn Turner, Ph.D., Senior Vice President of Worldwide Licensing &
External Research for Merck Research Laboratories, will deliver Tuesday's
keynote luncheon address entitled "Opportunities for Early Stage Companies
to Partner with Big Pharma."
For more information about BIO VentureForum East, please visit
http://bvf-east.bio.org/opencms/bvfeast/2006/index.jsp .
Registration is complimentary for credentialed members of the news
media. Reporters and editors working full-time for print or broadcast news
organizations may register onsite with valid media credentials.
BIO represents more than 1,100 biotechnology companies, academic
institutions, state biotechnology centers and related organizations across
the United States and in 31 other nations. BIO members are involved in the
research and development of health-care, agricultural, industrial and
environmental biotechnology products.
SOURCE Biotechnology Industry Organization
 back to top
Related links:
http://www.bio.org
CONTACT:
Stephanie Fischer of Biotechnology Industry
Organization, +1-202-312-9263
|
